- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 8th, 2006
NanoNovus: May 8
Jack Uldrich: This article from the Miami Herald provides a good overview of nanotechnology’s ability (and limitations) to detect cancer at an early stage. On the positive side, nanotechnology is leading to the development and creation of new diagnostic technologies that can detect unique “biomarkers”–specific proteins that show up when a cancer is present.
On the down side, these biomarkers are not always either sensitive or specific to a single disease. This suggests that even if new diagnostic technologies are developed, they might not do that much good.
|Related News Press|
Forge Nano raises $20 million in Series A Funding: Nano coating technology innovator Forge Nano will use funding to expand manufacturing capacity and grow Lithium-Ion battery opportunities November 3rd, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016